Contract Research Organization Services (CROs) Market

The report "Contract Research Organization (CRO) Services Market by Type (Early Phase, Clinical, Lab, Consulting), Therapeutic Area [Oncology (Breast, Lung), Infectious, Neurology, Vaccines], Modality, Model (FSO, FSP), End User, Competition - Global Forecast to 2031" is expected to reach USD 140.32 billion in 2031 from USD 93.02 billion in 2026, at a CAGR of 8.6% during the forecast period.

Browse 650 market data Tables and 57 Figures spread through 450 Pages and in-depth TOC on "Contract Research Organization (CRO) Services Market by Type (Early Phase, Clinical, Lab, Consulting), Therapeutic Area [Oncology (Breast, Lung), Infectious, Neurology, Vaccines], Modality, Model (FSO, FSP), End User, Competition - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/contract-research-organization-service-market-167410116.html

The global CRO services market is expected to reach USD 140.32 billion in 2031 from USD 93.02 billion in 2026, at a CAGR of 8.6% during the forecast period. Some factors contributing to the growth of the global CRO services market include the increasing focus on precision medicine, the expanding pipeline of cell & gene therapies, and increasing technological advancements in clinical trials. Additionally, the growing focus on sustainability and green lab solutions presents growth opportunities for market players.

By modality, the medical devices segment is estimated to register the highest CAGR during the forecast period.

By modality, the CRO services market is segmented into small molecules, biologics, medical devices, and biosimilars. The biologics segment is projected to register the highest CAGR during the forecast period. This strong growth is attributed to the rapid expansion of biologics in the pharmaceutical industry and the rising development activity across monoclonal antibodies, recombinant proteins, vaccines, and other complex biologic therapies, all of which require specialized development and testing support. In addition, sponsors are increasingly outsourcing biologics development to improve speed, flexibility, and cost efficiency, further supporting the growth of this segment in the global CRO services market.

By end user, the medical device companies segment is expected to grow at the highest CAGR during the forecast period.

Based on end user, the CRO services market is segmented into pharmaceutical & biopharmaceutical companies, medical device companies, and academic institutes. The medical device companies segment is expected to grow at the fastest rate, owing to the increasing complexity and regulatory requirements associated with device development and approval, which are fueling demand for specialized CRO expertise to accelerate time-to-market. Additionally, many medical device companies are mid-sized or emerging players that lack in-house infrastructure for large-scale trials, making CRO partnerships a cost-effective solution.

The Asia Pacific region is expected to register the highest CAGR during the forecast period.

Based on the region, the CRO Services market is segmented into six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific region is expected to register the highest growth rate during the forecast period, owing to the presence of high-growth hotspots such as India, China, and Japan that are focused on advancing research capabilities. The growing prevalence of chronic diseases has further fueled the need to outsource clinical services & research activities to CROs, thereby supporting market growth in this region during the forecast period.

The market for CRO services is competitive, with key players strategizing to capture the market. Prominent players in the CRO services market are IQVIA Inc. (US), Laboratory Corporation of America Holdings (US), Thermo Fisher Scientific Inc. (US), ICON Plc (Ireland), WuXi AppTec (China), Syneos Health (US), and Charles River Laboratories (US), among others.

Don’t miss out on business opportunities in CRO services market .Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com